Literature DB >> 8328780

Enhancement of drug susceptibility in Plasmodium falciparum in vitro and Plasmodium berghei in vivo by mixed-function oxidase inhibitors.

A M Ndifor1, R E Howells, P G Bray, J L Ngu, S A Ward.   

Abstract

A number of compounds, as exemplified by verapamil and desipramine, have been shown to enhance the susceptibility of resistant malaria parasites to chloroquine. The mechanism by which these agents reverse resistance is still controversial but is though to involve alterations in drug transport causing an increase in steady-state drug concentrations. We have proposed that an alternative resistance mechanism may involve the metabolic deactivation of the drug in some resistant parasites via cytochrome P-450 mixed-function oxidases. If the hypothesis is true, it should be possible to alter drug susceptibility in malaria parasites by the use of agents known to inhibit or induce cytochrome P-450 activities. We have assessed the ability of known inhibitors of cytochrome P-450 enzymes (cimetidine, metyrapone, and alpha-naphthoflavone) to enhance chloroquine susceptibility in Plasmodium falciparum culture-adapted and wild-type isolates in vitro and P. berghei in vivo. In all three systems, the inhibitor cimetidine enhanced parasite susceptibility to chloroquine, and this increase in susceptibility was unrelated to changes in chloroquine steady-state concentrations in vitro or to alterations in host pharmacokinetics in vivo. Additionally, the cytochrome P-450 inducer phenobarbital produced slight decreases in P. falciparum drug susceptibility in vitro. We have compared the ability of the cytochrome P-450 inhibitors cimetidine and metyrapone to enhance drug susceptibility with that of verapamil by using wild-type malaria isolates obtained from Cameroon. Verapamil completely reversed resistance, i.e., to below the cutoff point of 70 nM, in all the resistant isolates. Cimetidine enhanced chloroquine susceptibility in 60% of the isolates and reduced 50% inhibitory concentrations by at least 43% in all the resistant isolates. The compounds tested had little or no effect on the 50% inhibitory concentrations for the susceptible isolates. The data support a possible role for detoxification in chloroquine resistance, and even in the absence of such a process we have observed apparent chemosensitization by agents whose common biological feature is the inhibition of cytochrome P-450 enzymes. Additionally, sensitization has been observed in wild-type isolates of P. falciparum obtained form immune residents of an area of endemicity as well as culture-adapted parasites.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8328780      PMCID: PMC187959          DOI: 10.1128/AAC.37.6.1318

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  32 in total

1.  Inhibition by chloroquine of a novel haem polymerase enzyme activity in malaria trophozoites.

Authors:  A F Slater; A Cerami
Journal:  Nature       Date:  1992-01-09       Impact factor: 49.962

2.  Antihistaminic drugs that reverse chloroquine resistance in Plasmodium falciparum.

Authors:  W Peters; R Ekong; B L Robinson; D C Warhurst; X Q Pan
Journal:  Lancet       Date:  1989-08-05       Impact factor: 79.321

3.  Determination of chloroquine and its desethyl metabolite in plasma, red blood cells and urine by liquid chromatography.

Authors:  G Alván; L Ekman; B Lindström
Journal:  J Chromatogr       Date:  1982-04-16

Review 4.  Inhibition of oxidative drug metabolism in microsomes.

Authors:  K J Netter
Journal:  Pharmacol Ther       Date:  1980       Impact factor: 12.310

5.  Chloroquine resistance of Plasmodium berghei: biochemical basis and countermeasures.

Authors:  R I Salganik; T G Pankova; T V Chekhonadskikh; T M Igonina
Journal:  Bull World Health Organ       Date:  1987       Impact factor: 9.408

6.  Plasmodium falciparum: modulation by calcium antagonists of resistance to chloroquine, desethylchloroquine, quinine, and quinidine in vitro.

Authors:  D E Kyle; A M Oduola; S K Martin; W K Milhous
Journal:  Trans R Soc Trop Med Hyg       Date:  1990 Jul-Aug       Impact factor: 2.184

7.  Reversal of chloroquine resistance in malaria parasite Plasmodium falciparum by desipramine.

Authors:  A J Bitonti; A Sjoerdsma; P P McCann; D E Kyle; A M Oduola; R N Rossan; W K Milhous; D E Davidson
Journal:  Science       Date:  1988-12-02       Impact factor: 47.728

8.  High level of sensitivity to chloroquine of 72 Plasmodium falciparum isolates from southern Cameroon in January 1985.

Authors:  P Brasseur; P Druilhe; J Kouamouo; O Brandicourt; M Danis; S R Moyou
Journal:  Am J Trop Med Hyg       Date:  1986-07       Impact factor: 2.345

9.  The chemotherapy of rodent malaria. XLVI. Reversal of mefloquine resistance in rodent Plasmodium.

Authors:  W Peters; B L Robinson
Journal:  Ann Trop Med Parasitol       Date:  1991-02

10.  Reversal of chloroquine resistance in Plasmodium falciparum by verapamil.

Authors:  S K Martin; A M Oduola; W K Milhous
Journal:  Science       Date:  1987-02-20       Impact factor: 47.728

View more
  3 in total

Review 1.  Clinical pharmacokinetics and metabolism of chloroquine. Focus on recent advancements.

Authors:  J Ducharme; R Farinotti
Journal:  Clin Pharmacokinet       Date:  1996-10       Impact factor: 6.447

2.  Drug-regulated expression of Plasmodium falciparum P-glycoprotein homologue 1: a putative role for nuclear receptors.

Authors:  David J Johnson; Andrew Owen; Nick Plant; Patrick G Bray; Stephen A Ward
Journal:  Antimicrob Agents Chemother       Date:  2008-01-14       Impact factor: 5.191

3.  In vitro antimalarial activity of penduline, a bisbenzylisoquinoline from Isopyrum thalictroides.

Authors:  A Valentin; F Benoit-Vical; C Moulis; E Stanislas; M Mallié; I Fouraste; J M Bastide
Journal:  Antimicrob Agents Chemother       Date:  1997-10       Impact factor: 5.191

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.